Journal article
Diffusion-weighted magnetic resonance imaging for tumour response assessment: why, when and how?
Cancer imaging, Vol.10 Spec no A(1A), pp.S179-S188
10/04/2010
DOI: 10.1102/1470-7330.2010.9032
PMCID: PMC2967137
PMID: 20880779
Abstract
Diffusion-weighted magnetic resonance imaging (DWI) is increasingly being used to assess tumour response to a variety of anticancer treatments. The technique is quick to perform without the need for administration of exogenous contrast medium, and enables the apparent diffusion coefficient (ADC) of tissues to be quantified. Studies have shown that ADC increases in response to a variety of treatments including chemotherapy, radiotherapy, minimally invasive therapies and novel therapeutics. In this article, we review the rationale of applying DWI for tumour assessment, the evidence for ADC measurements in relation to specific treatments and some of the practical considerations for using ADC to evaluate treatment response.
Details
- Title: Subtitle
- Diffusion-weighted magnetic resonance imaging for tumour response assessment: why, when and how?
- Creators
- A Afaq - Royal Marsden HospitalA AndreouD M Koh
- Resource Type
- Journal article
- Publication Details
- Cancer imaging, Vol.10 Spec no A(1A), pp.S179-S188
- DOI
- 10.1102/1470-7330.2010.9032
- PMID
- 20880779
- PMCID
- PMC2967137
- ISSN
- 1470-7330
- eISSN
- 1470-7330
- Language
- English
- Date published
- 10/04/2010
- Academic Unit
- Radiology
- Record Identifier
- 9984318823402771
Metrics
7 Record Views